SARFEZPHARMA.COM: Keyword Density Checker

Total words: 1986 | 2-word phrases: 529 | 3-word phrases: 564 | 4-word phrases: 574

PAGE INFO

Title	Try to keep the title under 60 characters (13 characters) Home \| Sarfez
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	increased risk of	3	0.53%
2	sarfez pharmaceuticals inc	3	0.53%
3	risk of renal	2	0.35%
4	vienna va 22182	2	0.35%
5	antiinflammatory drugs nsaid	2	0.35%
6	a loop diuretic	2	0.35%
7	patients should be	2	0.35%
8	with heart failure	2	0.35%
9	associated with heart	2	0.35%
10	edema associated with	2	0.35%
11	of edema associated	2	0.35%
12	treatment of edema	2	0.35%
13	heart failure or	2	0.35%
14	warnings and precautions	2	0.35%
15	incidences of hypokalemia	2	0.35%
16	substrates or of	1	0.18%
17	warfarin or phenytoin	1	0.18%
18	as warfarin or	1	0.18%
19	impairment 77	1	0.18%
20	such as warfarin	1	0.18%
21	narrow therapeutic range	1	0.18%
22	a narrow therapeutic	1	0.18%
23	with a narrow	1	0.18%
24	substrates with a	1	0.18%
25	of substrates with	1	0.18%
26	or of substrates	1	0.18%
27	toxicity 75	1	0.18%
28	renal impairment 77	1	0.18%
29	cyp2c9 substrates or	1	0.18%
30	safety of sensitive	1	0.18%

#	Keyword	Frequency	Density
1	treatment of edema associated	2	0.35%
2	of edema associated with	2	0.35%
3	edema associated with heart	2	0.35%
4	associated with heart failure	2	0.35%
5	with heart failure or	2	0.35%
6	top of page sarfez	1	0.17%
7	therapy due to adverse	1	0.17%
8	of patients treated with	1	0.17%
9	6 of patients treated	1	0.17%
10	in 6 of patients	1	0.17%
11	occurred in 6 of	1	0.17%
12	of page sarfez logopng	1	0.17%
13	due to adverse reactions	1	0.17%
14	of therapy due to	1	0.17%
15	treated with soaanz 61	1	0.17%
16	discontinuation of therapy due	1	0.17%
17	reactions discontinuation of therapy	1	0.17%
18	adverse reactions discontinuation of	1	0.17%
19	fall in blood pressure	1	0.17%
20	in blood pressure with	1	0.17%
21	ototoxicity 53 76	1	0.17%
22	52 ototoxicity 53	1	0.17%
23	periodically 52 ototoxicity	1	0.17%
24	glucose periodically 52	1	0.17%
25	blood glucose periodically 52	1	0.17%
26	and blood glucose periodically	1	0.17%
27	patients treated with soaanz	1	0.17%
28	with soaanz 61 to	1	0.17%
29	blood pressure with the	1	0.17%
30	perspiration diarrhea or vomiting	1	0.17%
31	that inadequate fluid intake	1	0.17%
32	reduced diuretic natriuretic and	1	0.17%
33	nsaids reduced diuretic natriuretic	1	0.17%
34	drugs nsaids reduced diuretic	1	0.17%
35	antiinflammatory drugs nsaids reduced	1	0.17%
36	excessive perspiration diarrhea or	1	0.17%
37	wwwfdagovmedwatch drug interactions nonsteroidal	1	0.17%
38	or wwwfdagovmedwatch drug interactions	1	0.17%
39	1800fda1088 or wwwfdagovmedwatch drug	1	0.17%
40	at 1800fda1088 or wwwfdagovmedwatch	1	0.17%

#	URL	Whois	Check
1	https://www.sarfez.com	Whois	sarfez.com
2	https://www.sarfez.com/request-sample	Whois	sarfez.com
3	https://www.sarfez.com/home	Whois	sarfez.com
4	https://www.sarfez.com/scientificadvisorboard	Whois	sarfez.com
5	https://www.sarfez.com/technology	Whois	sarfez.com
6	https://www.sarfez.com/pipeline	Whois	sarfez.com
7	https://www.sarfez.com/contact	Whois	sarfez.com
8	https://www.sarfez.com/patients	Whois	sarfez.com
9	https://www.soaanz.com/	Whois	soaanz.com
10	https://www.marleydrug.com/soaanz?utm_source=SOAANZWebsite&utm_medium=SOAANZWebsite&utm_campaign=SOAANZWebsite&utm_id=SOAANZWebsite	Whois	marleydrug.com
11	https://www.goodrx.com/soaanz?form=tablet&dosage=40mg&defaultQuantity=30&manufacturer=BRAND	Whois	goodrx.com
12	http://www.fda.gov/medwatch	Whois	fda.gov
13	https://www.facebook.com/Soaanzforheartfailure	Whois	facebook.com
14	https://www.linkedin.com/company/sarfez-pharmaceutical-inc	Whois	linkedin.com